Form 4: Merit Medical Systems COO Neil Peterson Executes Stock Options and Sells Shares

Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options and sold 5,000 shares of common stock on March 3, 2025, according to a Form 4 filing with the SEC.

Summary

• On March 3, 2025, Neil Peterson, the Chief Operating Officer of Merit Medical Systems, exercised non-qualified stock options to acquire 5,000 shares of common stock at a price of $54.40 per share.
• Simultaneously, Peterson sold 5,000 shares of Merit Medical Systems common stock at a price of $105 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2024.
• Following these transactions, Peterson directly owns 28,369 shares of Merit Medical Systems common stock.
• Peterson also holds non-qualified stock options for an additional 48,576 shares at exercise prices of $68.33 and $70.58.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The sale was executed at $105, significantly higher than the option exercise price of $54.40, indicating a profitable transaction for Peterson.
• The transactions were pre-planned under a Rule 10b5-1 trading plan, suggesting they were not based on insider information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Comparing Peterson's transactions to those of other executives in similar medical device companies would require analyzing their Form 4 filings.
• Generally, the use of 10b5-1 plans is widespread among corporate executives to manage their stock holdings in a compliant manner.
• The profitability of the option exercise and sale depends on the specific terms of the options and the market price of MMSI stock at the time of the transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, potentially influencing the stock price in the short term.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates